Site mutation analysis revealed that ubiquitination at STAT6 K450 plays a crucial role in TRAF3-mediated STAT6 activation, which promotes increased expression of M2-associated surface markers as well as tumor progression. This evidence concerns the gene TRAF3 and neoplasm.